• $14.7M
    Market Cap
  • 92.09%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-1.7M
+0.84%
-1.7M
+21.83%
-1.4M
+22,356.36%
-6,150
+25.38%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Operating Expenses
3.4M
-6.31%
3.7M
+7.41%
3.4M
+417.53%
657,926
+102.19%
Operating Profit
-3.4M
-6.31%
-3.7M
+7.41%
-3.4M
+417.53%
-657,926
+102.19%
Interest Income
126,316
-60.30%
318,208
-16.01%
378,844
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
-23,234
+56.59%
Interest Income and Expense and Net
126,316
-60.30%
318,208
-16.01%
378,844
+1,730.56%
-23,234
+56.59%
Total Nonoperating Income and Expense
N/A
N/A
N/A
N/A
N/A
N/A
23,234
+256.59%
Income before Taxes
-3.4M
-6.31%
-3.7M
+20.86%
-3.0M
-124.88%
12.2M
+3,837.41%
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
55,109
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
N/A
N/A
N/A
N/A
-3.0M
-125.00%
12.1M
+4,153.90%
Net Income from Continuing Operations Applicable to Common
N/A
N/A
N/A
N/A
-3.0M
-125.39%
11.9M
+4,090.59%
Basic EPS and Net Income
-0.02
0.00%
-0.02
0.00%
-0.02
-166.67%
0.03
N/A
Diluted EPS and Net Income
-0.02
0.00%
-0.02
0.00%
-0.02
-166.67%
0.03
N/A
Basic Weighted Average Shares
172.5M
+0.14%
172.3M
+0.18%
172.0M
-53.04%
366.2M
-2.67%
Diluted Weighted Average Shares
172.5M
+0.14%
172.3M
+0.18%
172.0M
-53.25%
367.8M
-2.25%
Balance Sheet
Cash and Cash Equivalents
2.4M
-57.63%
5.6M
-36.57%
8.8M
-26.03%
12.0M
+38,923.13%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.4M
-57.63%
5.6M
-36.57%
8.8M
-26.03%
12.0M
+38,923.13%
Total Current Assets
2.4M
-57.03%
5.7M
-36.37%
8.9M
-25.27%
12.0M
+20,271.40%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Assets
2.5M
-55.90%
5.7M
-36.37%
8.9M
-25.27%
12.0M
+20,271.40%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
24,724
N/A
N/A
N/A
411,000
0.00%
411,000
+77.92%
Total Current Liabilities
766,330
+7.99%
709,618
+6.68%
665,164
-2.01%
678,782
-0.12%
Total Long-Term Debt
36,889
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
3.0M
0.00%
3.0M
0.00%
3.0M
0.00%
3.0M
0.00%
Total Liabilities
3.8M
+2.52%
3.7M
+1.21%
3.7M
-0.37%
3.7M
-0.02%
Retained Earnings
-55.4M
+6.33%
-52.1M
+6.85%
-48.8M
+6.61%
-45.8M
-20.66%
Total Stockholders Equity
-1.3M
-165.08%
2.0M
-62.43%
5.3M
-36.31%
8.3M
+329.13%
Total Shares Outstanding
172.6M
+0.15%
172.3M
+0.17%
172.0M
+0.13%
171.8M
-54.41%
Cash Flow
Cash from Operating Activities
-3.2M
-0.05%
-3.2M
+19.73%
-2.7M
-123.00%
11.7M
+5,426.15%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
N/A
N/A
N/A
N/A
-411,000
-328.33%
180,000
+2.27%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
N/A
N/A
N/A
N/A
-28.92%
-114.38%
201.20%
+164.19%
Return on Equity
N/A
N/A
N/A
N/A
-44.57%
-108.61%
517.86%
+5,952.93%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
3.19
-60.21%
8.03
-40.35%
13.45
-23.74%
17.64
+20,295.49%
Cash Ratio
3.10
-60.77%
7.90
-40.55%
13.29
-24.52%
17.61
+38,939.69%
Debt-to-Equity Ratio
-0.05
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.02
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow